Építés alatt – nem éles oldal
Belépés

Tüdőrák trials, also abroad

2746 open Tüdőrák trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

OrszágOpen trials
Kína1144
Egyesült Államok900
Franciaország316
Spanyolország274
Olaszország272
All other countries

The same trial often runs in several countries

A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) has 8 sites in Ukrajna and runs in 36 countries. If a site near you is full, another one may still take people.

See A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) in all 36 countries
Építés alatt, nem éles – Tüdőrák: vizsgálatok itt: Ukrajna – Frontlight Research